FDA Approves First Treatment for Rare Thyroid Hormone Disorder
(MedPage Today) -- The FDA approved tiratricol (Emcitate) to treat peripheral thyrotoxicosis in patients with monocarboxylate transporter 8 (MCT8) deficiency, the agency announced on Monday, marking the first approval for this rare genetic disorder...
We haven't written up this one. MedPage Today has the full story — the link below goes straight to it.